Under construction – not a live service
Sign in
Not yet taking people in GermanyNo phase

Registry Following People With Blood Disorders Called MDS and Related Conditions

Follows people with myelodysplastic syndrome and related blood conditions over time.

Plain-language title generated from the registry record
Registry title: Dresden MDS Registry With an Accompanying Biomaterial Collection

Key facts

Where
Dresden, GermanySee the site

Where in Germany

  • Universitätsklinikum Carl Gustav Carus DresdenDresden, GermanyNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Technische Universität Dresden
Trial code
NCT07561385
Record updated
27 August 2026
Original description
A registry for the study of the epidemiology, clinical course, and progression of myelodysplastic neoplasms (MDS), myelodysplastic/myeloproliferative neoplasms (MDS/MPN overlap syndromes), and their precursor syndromes (CHIP, CCUS)Read full original descriptionShow less

Dresden MDS Registry With an Accompanying Biomaterial Collection

A registry for the study of the epidemiology, clinical course, and progression of myelodysplastic neoplasms (MDS), myelodysplastic/myeloproliferative neoplasms (MDS/MPN overlap syndromes), and their precursor syndromes (CHIP, CCUS)

Inclusion: Diagnosis of myelodysplastic syndrome (MDS), MDS/MPN overlap syndrome or evidence of myelodysplastic precursor syndrome, defined as clonal haematopoiesis without cytopenia (clonal haematopoiesis of indeterminate potential, CHIP) or clonal haematopoiesis with cytopenia (clonal cytopenia of undetermined significance, CCUS) in accordance with current WHO criteria; Age ≥18 years; Submission of a signed consent form for participation in the MDS Registry.

Exclusion: No exclusion criteria have been established with regard to the registry's primary objective. In particular, patients with comorbidities and those receiving non-curative treatment may be explicitly included in order to provide a realistic picture of actual care practices; Inclusion in the registry is excluded in cases where a written consent form is not available or where patients are unable to understand the nature and implications of participating in this registry.

ClinicalTrials.gov NCT07561385